Immatics N.V.
IMTXNASDAQHealthcare● Active
$9.55
$-0.24(-2.45%)
Market Cap$1.3B
P/E Ratio—
52W High$12.41
52W Low$5.05
Immatics N.V. (IMTX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IMTX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.50
Est. -$0.42 · -19.1%
Revenue
$0.01B
Est. $0.01B · -10.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
IMTX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.49 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.42 | -$0.50 | -19.1% | $0.01B | $0.01B | -10.3% |
| ▲ Q1 FY2026 | Mar 5, 2026 | -$0.48 | -$0.34 | +29.2% | $0.02B | $0.01B | +98.2% |
| ▼ Q4 FY2025 | Nov 17, 2025 | -$0.44 | -$0.49 | -11.5% | $0.01B | $0.01B | -43.3% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.38 | -$0.66 | -73.7% | $0.01B | $0.01B | -55.5% |
| ▲ Q2 FY2025 | May 13, 2025 | -$0.39 | -$0.35 | +10.3% | $0.02B | $0.01B | +50.8% |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.33 | $0.48 | +245.4% | $0.06B | $0.02B | +145.6% |
| ▲ Q4 FY2024 | Nov 18, 2024 | -$0.27 | -$0.12 | +55.6% | $0.06B | $0.02B | +243.2% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.49
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.50
EPS Est.
-$0.42
EPS Surpr.
-19.1%
Revenue
$0.01B
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
-$0.34
EPS Est.
-$0.48
EPS Surpr.
+29.2%
Revenue
$0.02B
Q4 FY2025
Nov 17, 2025Miss
EPS Actual
-$0.49
EPS Est.
-$0.44
EPS Surpr.
-11.5%
Revenue
$0.01B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.66
EPS Est.
-$0.38
EPS Surpr.
-73.7%
Revenue
$0.01B
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$0.35
EPS Est.
-$0.39
EPS Surpr.
+10.3%
Revenue
$0.02B
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
$0.48
EPS Est.
-$0.33
EPS Surpr.
+245.4%
Revenue
$0.06B
Q4 FY2024
Nov 18, 2024Beat
EPS Actual
-$0.12
EPS Est.
-$0.27
EPS Surpr.
+55.6%
Revenue
$0.06B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.59 | $-0.46 | $-0.24 | 1 |
| Q3 FY2027 | $-0.67 | $-0.52 | $-0.27 | 1 |
| Q2 FY2027 | $-0.67 | $-0.52 | $-0.27 | 1 |
| Q1 FY2027 | $-0.65 | $-0.50 | $-0.26 | 1 |
| Q4 FY2026 | $-0.53 | $-0.42 | $-0.22 | 1 |
| Q3 FY2026 | $-0.53 | $-0.45 | $-0.36 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -19.1% | $11.54 | $11.39 | -1.30% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +29.2% | $10.18 | $10.15 | -0.29% |
| ▼ Q4 FY2025 | Nov 17, 2025 | -11.5% | $10.20 | $9.47 | -7.16% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -73.7% | $6.42 | $6.10 | -4.98% |
| ▲ Q2 FY2025 | May 13, 2025 | +10.3% | $4.56 | $4.34 | -4.82% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +245.4% | $4.53 | $4.71 | +3.97% |
| ▲ Q4 FY2024 | Nov 18, 2024 | +55.6% | $8.17 | $7.82 | -4.28% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +48.6% | $11.37 | $11.51 | +1.23% |
Q2 FY2026-1.30%
Report Date
May 12, 2026
EPS Beat/Miss
-19.1%
Price Before
$11.54
Price After
$11.39
Q1 FY2026-0.29%
Report Date
Mar 5, 2026
EPS Beat/Miss
+29.2%
Price Before
$10.18
Price After
$10.15
Q4 FY2025-7.16%
Report Date
Nov 17, 2025
EPS Beat/Miss
-11.5%
Price Before
$10.20
Price After
$9.47
Q3 FY2025-4.98%
Report Date
Aug 13, 2025
EPS Beat/Miss
-73.7%
Price Before
$6.42
Price After
$6.10
Q2 FY2025-4.82%
Report Date
May 13, 2025
EPS Beat/Miss
+10.3%
Price Before
$4.56
Price After
$4.34
Q1 FY2025+3.97%
Report Date
Mar 27, 2025
EPS Beat/Miss
+245.4%
Price Before
$4.53
Price After
$4.71
Q4 FY2024-4.28%
Report Date
Nov 18, 2024
EPS Beat/Miss
+55.6%
Price Before
$8.17
Price After
$7.82
Q3 FY2024+1.23%
Report Date
Aug 13, 2024
EPS Beat/Miss
+48.6%
Price Before
$11.37
Price After
$11.51
Avg Beat Reaction-0.84%
Avg Miss Reaction-4.48%
Beat Rate5 / 8 quarters
Largest Move-7.16% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IMTX ends December
Immatics N.V. (IMTX) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.50 — missing the analyst consensus of $-0.42 by -19.1%. The next IMTX earnings date is expected around September 1, 2026.
Each quarter, investors track IMTX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IMTX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IMTX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IMTX earnings · 5 questionsImmatics N.V.'s next earnings report is expected around September 1, 2026. IMTX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IMTX historically reports after market close (AMC).
IMTX earnings datewhen is IMTX earningsIMTX next earnings datewhen does IMTX report earningsIMTX earnings calendar
▸ Source: FMP · Immatics N.V. SEC filings · US GAAP · Immatics N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026